Eli Lilly and Co (LLY) Stock News

Rosen Law Firm is reminding investors who purchased Peabody Energy common stock between October 14, 2024 and May 4, 2026 of an important August 24, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Peabody Energy provided misleading statements about its Centurion mine operations, with the company significantly lowering guidance in March 2026 when actual output was approximately 250,000 tons versus previously estimated 700,000 tons due to mining commissioning challenges.

Rosen Law Firm is reminding investors in Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) of an August 17, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that defendants made materially false statements and failed to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' which materially impacted financial results.

Rosen Law Firm is reminding investors in Via Transportation, Inc. (NYSE: VIA) of an August 10, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Via's IPO offering documents were false and misleading, omitting information about declining Platform Annual Run-Rate Revenue and inability to grow in Germany. Via shares have declined approximately 70% from the IPO price to $14.52.

Rosen Law Firm is alerting Sportradar Group AG investors who purchased shares between November 7, 2024 and April 21, 2026 about a July 17, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Sportradar made false statements about compliance and ethics while secretly working with black-market gambling operators and maintaining inadequate Know-Your-Customer processes.

Rosen Law Firm has filed a class action lawsuit on behalf of Genius Group Limited (GNS) investors who purchased or sold securities between April 12, 2022 and May 30, 2025. The lawsuit alleges that Citadel Securities LLC and Virtu Americas LLC engaged in illegal 'spoofing' practices—submitting and cancelling orders without intent to execute them—to manipulate stock prices and mislead market participants about supply, demand, and volatility. The deadline to serve as lead plaintiff is August 28, 2026.

Rosen Law Firm announces securities class action lawsuits against FS KKR Capital Corp. (FSK) and ChampionX Corporation (CHX). FSK investors with losses exceeding $100K are urged to act before the July 6, 2026 deadline, with allegations including overstated portfolio valuations and misleading statements about business operations. CHX has a similar deadline of July 14, 2026.

Rosen Law Firm announces securities class action lawsuits against AeroVironment, Calix, and Sportradar Group, alleging that defendants made false or misleading statements regarding business prospects and competitive positioning. Investors with losses exceeding $100K are encouraged to join the class actions before upcoming deadlines.

Rosen Law Firm is encouraging investors who purchased Badger Meter common stock between April 18, 2024 and April 16, 2026 to join a securities class action lawsuit. The lawsuit alleges that Badger Meter made materially false and misleading statements about its financial results and growth prospects by concealing a practice of pulling forward customer orders to recognize revenue early, which masked weakening demand and deteriorating order trends. The lead plaintiff deadline is August 3, 2026.

Rosen Law Firm has filed a class action lawsuit against Embecta Corp. on behalf of investors who purchased common stock between November 25, 2025 and May 4, 2026. The lawsuit alleges that Embecta made false and misleading statements about its fiscal results and guidance, particularly regarding its pen needle business, which it described as 'incredibly resolute' before subsequently missing expectations and cutting 2026 fiscal guidance. Investors who purchased shares during this period may be entitled to compensation. The deadline to serve as lead plaintiff is August 17, 2026.

Rosen Law Firm is encouraging investors who purchased securities of Nano-X Imaging Ltd. (NNOX) between March 31, 2025 and April 17, 2026 to join a class action lawsuit. The firm alleges that Nano-X made false statements about operational efficiency and product demand, while concealing poor manufacturing alignment, increased operating expenses, and cash burn. The lead plaintiff deadline is August 11, 2026. The firm is also investigating potential securities claims for ADMA Biologics and DNOW Inc.

Rosen Law Firm is urging investors in Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) to join a securities class action lawsuit with an August 17, 2026 deadline for lead plaintiff claims. The lawsuit alleges that defendants made materially false statements and failed to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' materially impacting financial results during the class period from September 12, 2025 to May 12, 2026.

Rosen Law Firm has filed a class action lawsuit against Black Rock Coffee Bar, Inc. (NASDAQ: BRCB) on behalf of investors who purchased securities during the company's September 2025 IPO and through May 12, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding the company's expansion strategy, failing to disclose that new store openings were cannibalizing existing revenue through 'sales transfer,' which materially impacted financial results. The deadline to serve as lead plaintiff is August 17, 2026.

Rosen Law Firm is reminding investors who purchased GRAIL, Inc. common stock between May 13, 2025 and February 19, 2026 of an important August 4, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that GRAIL provided overwhelmingly positive statements while concealing material adverse facts about its NHS-Galleri trial, including that the trial period was insufficient to demonstrate the primary endpoint of reducing Stage III-IV cancers.

Rosen Law Firm is reminding investors who purchased GRAIL, Inc. common stock between May 13, 2025 and February 19, 2026 of an important August 4, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that GRAIL provided overwhelmingly positive statements while concealing material adverse facts about its NHS-Galleri trial, including that the trial period was insufficient to demonstrate the primary endpoint of reducing Stage III-IV cancers.

Rosen Law Firm announces securities class action lawsuits against Regencell Bioscience Holdings Limited, Sportradar Group AG, and TruBridge, Inc. Investors with losses exceeding $100,000 are encouraged to join the litigation before the June 23, 2026 deadline. The lawsuits allege false and misleading statements regarding market manipulation, regulatory risks, and undisclosed material information.

Rosen Law Firm is urging investors who purchased Graphic Packaging Holding Company (GPK) securities between February 4, 2025 and February 2, 2026 to join a class action lawsuit. The lawsuit alleges that the company made false statements regarding inventory management issues, reduced demand, increased costs, and overstated its business model strength. Investors must act by the July 6, 2026 lead plaintiff deadline.

Rosen Law Firm is urging Stellantis N.V. investors who purchased stock between February 26, 2025 and February 5, 2026 to join a securities class action lawsuit before the June 8, 2026 deadline. The lawsuit alleges that Stellantis made false statements about its earnings growth potential and electrification strategy, and was not well-positioned to capitalize on EV opportunities, ultimately requiring significant charges to shift away from battery-powered electric vehicles.

Rosen Law Firm reminds Stellantis N.V. investors of the June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Stellantis made false statements about its earnings growth potential and electrification strategy, claiming the company was not well-positioned for battery-powered electric vehicle growth and would need to take significant charges to adjust its priorities.

Rosen Law Firm has filed a class action lawsuit on behalf of Veritone, Inc. investors who purchased securities between October 14, 2025 and April 14, 2026. The lawsuit alleges that Veritone made false statements and failed to disclose inaccurate revenue recording, misclassified costs, overstated financial metrics, and maintained deficient internal controls, leading to required financial statement restatements. Investors who wish to serve as lead plaintiff must file by July 20, 2026.

Rosen Law Firm announces securities class action lawsuits against ImmunityBio, Inc. and other companies for allegedly making false and misleading statements. The firm is seeking lead plaintiffs with losses exceeding $100,000 before the May 26, 2026 deadline. According to the lawsuit, ImmunityBio's defendant Patrick Soon-Shiong materially overstated Anktiva's capabilities, resulting in false statements about the company's business and prospects.

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against Aldeyra Therapeutics, alleging the company made false and misleading statements about reproxalap clinical trial results. The lawsuit covers purchases between November 3, 2023 and March 16, 2026, with a lead plaintiff deadline of May 29, 2026.